Fig. 4

ROC curve for the combination of AFP and miR-331-3p to predict early-stage HCC patients (group II) from HCV-related cirrhosis (group I)
ROC curve for the combination of AFP and miR-331-3p to predict early-stage HCC patients (group II) from HCV-related cirrhosis (group I)